Cronos (CRON) Gross Margin (2018 - 2026)

Cronos' (CRON) quarterly Gross Margin came in at 42.36% in Q1 2026, down 10016.0% year-on-year from N/an in Q1 2025, and up 16.53% quarter-over-quarter from 36.35% in Q4 2025.

Cronos (CRON) Gross Margin (2018 - 2026) Analysis & Trends

Cronos' Gross Margin history runs 9 years deep, the most recent figure standing at 42.36% for Q1 2026.

  • On a quarterly basis, Gross Margin fell 10016.0% year-over-year to 42.36% in Q1 2026; TTM through Mar 2026 was 45.64%, a 1414.0% decrease from a year earlier, with the FY2025 full-year figure at 42.81%, up 2139.0% from the prior year.
  • Gross Margin improved to 42.36% in Q1 2026 per CRON's latest filing, from 36.35% in the prior quarter.
  • Across five years, Gross Margin topped out at 142.53% in Q1 2025 and bottomed at 357.37% in Q4 2024.
  • The 5-year median for Gross Margin is 17.73% (2024), against an average of 13.68%.
  • Across the five-year window, Gross Margin tumbled 36537 bps in 2024 and surged 39373 bps in 2025, its largest moves.
  • Year by year, Gross Margin stood at 2.99% in 2022, then soared by 368 bps to 8.0% in 2023, then tumbled by 4568 bps to 357.37% in 2024, then jumped by 110 bps to 36.35% in 2025, then advanced by 17 bps to 42.36% in 2026.
  • Per Business Quant, the three latest CRON Gross Margin figures stand at 42.36% (Q1 2026), 36.35% (Q4 2025), and 37.54% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 Cronos 1.04 Bn 267.78 Mn 19.15 Mn 42.36%

Historic Data

Download Data
DateValue
Mar 31, 2026 42.36%
Dec 31, 2025 36.35%
Sep 30, 2025 37.54%
Jun 30, 2025 134.33%
Mar 31, 2025 142.53%
Dec 31, 2024 -357.37%
Sep 30, 2024 29.29%
Jun 30, 2024 16.28%
Mar 31, 2024 17.73%
Dec 31, 2023 8.00%
Sep 30, 2023 16.00%
Jun 30, 2023 12.01%
Mar 31, 2023 41.46%
Dec 31, 2022 -2.99%
Sep 30, 2022 15.40%
Jun 30, 2022 15.95%
Mar 31, 2022 27.67%
Dec 31, 2021 29.12%
Sep 30, 2021 -17.45%
Jun 30, 2021 -101.04%